TNFRSF8 and neoplasm: In contrast, a pro-apoptotic marker (CD30) was expressed at higher levels in cells lacking vIL-6 and some pro-growth markers (notably CD45) were upregulated cells with vIL-6 during tumor formation, suggesting that vIL-6 promotes cell growth and inhibition of apoptosis in vivo during solid tumor formation.